Osteopenia and Disability

Summary:

Disability is found among people with Osteopenia, especially for people who are female, 60+ old.

The study analyzes which people have Disability with Osteopenia. It is created by eHealthMe based on reports of 53 people who have Osteopenia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Osteopenia?

Osteopenia (a condition where bone mineral density is lower than normal) is found to be associated with 1,446 drugs and 1,170 conditions by eHealthMe. Check the latest studies of Osteopenia.

What is Disability?

Disability is found to be associated with 1,112 drugs and 797 conditions by eHealthMe. Check the latest studies of Disability.



On Jul, 13, 2026

53 people who have Osteopenia and Disability are studied.

Would you have Disability when you have Osteopenia?

Gender of people who have Osteopenia and experienced Disability *:

  • female: 60.47 %
  • male: 39.53 %

Age of people who have Osteopenia and experienced Disability *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.03 %
  • 40-49: 42.42 %
  • 50-59: 6.06 %
  • 60+: 48.48 %

Common co-existing conditions for these people *:

  1. Osteoporosis (bones weak and more likely to break): 20 people, 37.74%
  2. Gynecomastia (enlargement of the gland tissue of the male breast): 16 people, 30.19%
  3. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 16 people, 30.19%
  4. Thyroid Diseases: 9 people, 16.98%
  5. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 6 people, 11.32%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 5.66%
  7. Asthma: 2 people, 3.77%
  8. Hepatitis C: 1 person, 1.89%
  9. Bladder Spasm: 1 person, 1.89%
  10. Bone Density Decreased: 1 person, 1.89%

Common drugs taken by these people *:

  1. Fosamax: 43 people, 81.13%
  2. Aredia: 17 people, 32.08%
  3. Zometa: 17 people, 32.08%
  4. Avodart: 16 people, 30.19%
  5. Celebrex: 16 people, 30.19%
  6. Hydrocortisone: 16 people, 30.19%
  7. Lupron: 16 people, 30.19%
  8. Nizoral: 16 people, 30.19%
  9. Casodex: 15 people, 28.30%
  10. Tamoxifen Citrate: 15 people, 28.30%

Common symptoms for these people *:

  1. Stress And Anxiety: 35 people, 66.04%
  2. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 30 people, 56.60%
  3. Insomnia (sleeplessness): 30 people, 56.60%
  4. Osteomyelitis (infection of bone): 29 people, 54.72%
  5. Fatigue (feeling of tiredness): 26 people, 49.06%
  6. Sinusitis (inflammation of sinus): 24 people, 45.28%
  7. Osteonecrosis Of Jaw (death of bone of jaw): 24 people, 45.28%
  8. Headache (pain in head): 23 people, 43.40%
  9. Pain: 22 people, 41.51%
  10. High Blood Cholesterol: 22 people, 41.51%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Disability?

- Check whether Disability is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Disability:

All the conditions that are associated with Disability:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Disability and Osteopenia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: